Perfluorinated compounds: emerging POPs with potential immunotoxicity
about
A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humansPhlebotomy treatment for elimination of perfluoroalkyl acids in a highly exposed family: a retrospective case-series.Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion?Occurrence investigation of perfluorinated compounds in surface water from East Lake (Wuhan, China) upon rapid and selective magnetic solid-phase extraction.Involvement of mitogen-activated protein kinase and NF-κB signaling pathways in perfluorooctane sulfonic acid-induced inflammatory reaction in BV2 microglial cells.Obesity, Persistent Organic Pollutants and Related Health Problems.Effects of in vivo exposure to polyfluorinated dibenzo-p-dioxins on organo-somatic indices and ethoxyresorufin-O-deethylase activity in mice (Mus musculus).Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination.Cord blood gene expression supports that prenatal exposure to perfluoroalkyl substances causes depressed immune functionality in early childhood.Polar stir bars for isolation and preconcentration of perfluoroalkyl substances from human milk samples prior to UHPLC-MS/MS analysis.Environmental perfluorooctane sulfonate exposure drives T cell activation in bottlenose dolphins.Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.Cholesterol-like effects of a fluorotelomer alcohol incorporated in phospholipid membranes.Microbial toxicity and biodegradability of perfluorooctane sulfonate (PFOS) and shorter chain perfluoroalkyl and polyfluoroalkyl substances (PFASs).
P2860
Q28072372-B1771CC5-9721-49BC-BA62-899B608F3B53Q34689412-5DA11EA3-BC44-4886-9FA3-11924FBCB1A2Q35154969-6EEBE339-B359-46CA-9F54-1E974DD76400Q37501237-E618CA44-06C5-4F52-BC8E-F251EB39EAF1Q38910228-9A15FDCE-28B6-4742-B736-4B9BBAF6E524Q39353759-E8EDC159-63AC-4ADC-958E-F2566AE46D04Q40276523-D271C406-D402-4CB4-8F57-12FAABA0130BQ40379605-0BC082A0-2D78-4C01-AC64-9E1317E50802Q41154649-1FF9B704-CD73-4645-801B-BC0D77C07FB3Q46168337-ADEE9645-2DBA-433B-A1D4-F4F404C16A51Q46380449-EB8563F0-6FEB-4E7A-A35E-EF20DE6FA201Q47552199-EC08C5AF-38AA-4581-83B4-D503A9D75FC6Q47833635-0A13B05E-F2D2-46C6-B86D-39FF1B7B2D1DQ49389763-BD16C969-7185-4A59-AAD6-814199A8E3A4Q51143559-41540311-D6F1-4B0E-8199-5681CD135CAF
P2860
Perfluorinated compounds: emerging POPs with potential immunotoxicity
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Perfluorinated compounds: emerging POPs with potential immunotoxicity
@ast
Perfluorinated compounds: emerging POPs with potential immunotoxicity
@en
type
label
Perfluorinated compounds: emerging POPs with potential immunotoxicity
@ast
Perfluorinated compounds: emerging POPs with potential immunotoxicity
@en
prefLabel
Perfluorinated compounds: emerging POPs with potential immunotoxicity
@ast
Perfluorinated compounds: emerging POPs with potential immunotoxicity
@en
P2093
P2860
P1433
P1476
Perfluorinated compounds: emerging POPs with potential immunotoxicity
@en
P2093
Dori R Germolec
Emanuela Corsini
Robert W Luebke
P2860
P304
P356
10.1016/J.TOXLET.2014.01.038
P577
2014-02-03T00:00:00Z